CROSS-CULTURAL ADAPTATION AND VALIDATION OF THE BRADEN QD SCALE FOR USE WITH NEONATES IN BRAZIL

• Autor(a) principal: Santos,Simone Vidal
• Data de Publicação: 2022
• Outros Autores: Silveira,Jéssica Rodrigues, Costa,Roberta, Batalha,Luís Manuel da Cunha, Velho,Manuela Beatriz
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Texto & contexto enfermagem (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072022000100349
• topic: Methods; Validation studies; Neonatal nursing; Pediatric nursing; Pressure injury; Risk measurement

ABSTRACT Objective: to cross-culturally adapt and validate the Braden QD Scale for use with neonates in Brazil. Method: a methodological study of cross-cultural adaptation and observational cross-sectional validation study, carried out between December 2017 and August 2021. The participants were 10 specialists, 38 nurses and 105 newborns. The cross-cultural adaptation process involved the initial translation, synthesis, back-translation, expert committee, pre-test and approval of the adapted version of the original instrument by the author. Validation verified the validity, reliability and internal consistency psychometric properties, from simultaneous and independent application of the adapted instrument by two evaluators, and based on time evaluation from the video of five neonates at two different moments. The statistical tests performed were Content Validity Index, Cronbach's alpha and Kappa coefficient. Results: the Braden QD scale translation process resulted in the Portuguese version adapted for the Brazilian culture. The expert committee's Content Validity Index was ≥0.90 and that of the pre-test was ≥0.80. In interobserver reliability, all items obtained Kappa coefficients > 0.90. Cronbach's alpha was 0.773 and 0.769 for Evaluators 1 and 2, respectively, with Cronbach's alpha > 0.6 considered as reliable. In intraobserver agreement, the mean scores were not different in the practice. Conclusion: the instrument was cross-culturally adapted for use with neonates and children in Brazil. The Brazilian version presented statistical validity and reliability levels, proving to be valid for use in neonates in Brazil.